How many insider declarations has Snyder David S filed?

Snyder David S has filed 2 public insider declarations with SEC (Form 4).

What is Snyder David S's role?

Snyder David S's reported role is not specified by the regulator across the filings.

Which companies does Snyder David S report trades for?

Snyder David S reports trades for Coya Therapeutics, Inc..

What is Snyder David S's declared buy vs sell volume?

Across the available history, declared buys total 12k€ and disposals 0.

← Executives ★ Sign in to follow

SD

Snyder David S

·SEC (Form 4)

Coya Therapeutics, Inc.

0

申报总数

0

公司

€12,244

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the detailed record of transactions filed by Snyder David S. Insider active across 1 company, notably Coya Therapeutics, Inc.. In total, 2 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €12k. Activity tracked since 14 November 2024. The latest transaction was disclosed on 14 November 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Snyder David S

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Coya Therapeutics, Inc. (US)

申报2 总计

▲

SNYDER DAVID S

Chief Financial Officer高管2024年11月14日Coya Therapeutics, Inc.

US$12,93446SEC ↗

1,800 股@ US$7.1858100.0% 占其流量Common Stock, par value $0.0001 per shareSEC:0001493152-24-046106:0

标准退出：2025年2月12日 (T+90)

▲

SNYDER DAVID S

Chief Financial Officer高管2023年1月3日Coya Therapeutics, Inc.

0SEC ↗

7,000 股Common Stock, par value $0.0001 per shareSEC:0001493152-23-000224:0

标准退出：2023年4月3日 (T+90)

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

SD

Snyder David S

·SEC (Form 4)

Coya Therapeutics, Inc.

0

申报总数

0

公司

€12,244

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Explore the detailed record of transactions filed by Snyder David S. Insider active across 1 company, notably Coya Therapeutics, Inc.. In total, 2 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €12k. Activity tracked since 14 November 2024. The latest transaction was disclosed on 14 November 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Snyder David S

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Coya Therapeutics, Inc. (US)

申报2 总计

▲

SNYDER DAVID S

Chief Financial Officer高管2024年11月14日Coya Therapeutics, Inc.

US$12,93446SEC ↗

1,800 股@ US$7.1858100.0% 占其流量Common Stock, par value $0.0001 per shareSEC:0001493152-24-046106:0

标准退出：2025年2月12日 (T+90)

▲

SNYDER DAVID S

Chief Financial Officer高管2023年1月3日Coya Therapeutics, Inc.

0SEC ↗

7,000 股Common Stock, par value $0.0001 per shareSEC:0001493152-23-000224:0

标准退出：2023年4月3日 (T+90)

2 条申报中的 2 条

Snyder David S

内部人交易记录

Companies and markets linked to Snyder David S

Related entities

Snyder David S

内部人交易记录

Companies and markets linked to Snyder David S

Related entities